Nidlegy Marketing Authorization Application Submitted to EMA
First marketing authorisation submission for Nidlegy for the treatment of locally advanced, fully resectable melanoma in the…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Marketing Authorization Application
Eisai submits MAA for lecanemab in Great Britain to treat early Alzheimer’s disease
Lecanemab has been designated by the MHRA for the Innovative Licensing and Access Pathway